MULTICENTER EVALUATION OF MEMORY REMEDIATION AFTER TRAUMATIC BRAIN INJURYWITH DONEPEZIL: THE MEMRI-TBI-D STUDY

F
Flora Hammond, MD

Primary Investigator

J
Jessica MacLean

Primary Investigator

Not Recruiting
18 years - 60 years
All
Phase N/A
1 Location

Brief description of study

The purpose of this study is to determine whether donepezil is an effective treatment for memory problems among adults who experienced traumatic brain injury 6-35 months ago.

Detailed description of study

This study is a four-site, randomized, parallel design, double-blind, placebo-controlled, 10-week trial that will evaluate the effect of donepezil on treatment for functionally important verbal memory problems among 160 individuals (age 18-60 years) who sustained a complicated mild, moderate, or severe non-penetrating TBI six to 36 months prior to study participation.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: traumatic brain injury
  • Age: 18 years - 60 years
  • Gender: All
Updated on 02 Oct 2014. Study ID: 1402587492

Interested in the study?

Select a study center that’s convenient for you, and get in touch with the study team.

Connect with the Study Team